Purple Biotech Ltd. - American Depositary Shares (NQ:PPBT)

4.005 +0.015 (+0.38%)

Streaming Delayed Price Updated: 1:54 PM EDT, Mar 27, 2026 Add to My Watchlist

Price and Volume

Volume	5,263
Open	3.930
Bid (Size)	3.850 (400)
Ask (Size)	4.010 (100)
Prev. Close	3.990
Today's Range	3.850 - 4.210
52wk Range	0.4100 - 5.180
Shares Outstanding	17,210,574
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform

March 25, 2026

From Purple Biotech Ltd.

Via GlobeNewswire

Purple Biotech Regains Compliance with Nasdaq

March 17, 2026

From Purple Biotech Ltd.

Via GlobeNewswire

Performance

YTD	+506.5%	+506.5%
1 Month	+691.7%	+691.7%
3 Month	+467.5%	+467.5%
6 Month	+593.5%	+593.5%
1 Year	+48.9%	+48.9%

More News

Purple Biotech Announces CEO Transition

March 13, 2026

From Purple Biotech Ltd.

Via GlobeNewswire

Purple Biotech Announces Plan to Implement ADS Ratio Change

February 25, 2026

From Purple Biotech Ltd.

Via GlobeNewswire

Purple Biotech Achieves Toxicology Milestone Demonstrating an Expanded Therapeutic Window for CAPTN-3 Platform Tri-specific Antibody, IM1240

January 07, 2026

From Purple Biotech Ltd.

Via GlobeNewswire

Get insights into the top gainers and losers of Tuesday's after-hours session. ↗

December 16, 2025

Via Chartmill

Purple Biotech Reports Positive New Preclinical Data Demonstrating Multi-Arm Anti-Tumor Activity Across Two CAPTN-3 Tri-Specific Antibodies at ESMO Immuno-Oncology Congress 2025

December 11, 2025

From Purple Biotech Ltd.

Via GlobeNewswire

Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress

December 04, 2025

From Purple Biotech Ltd.

Via GlobeNewswire

Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update

November 14, 2025

From Purple Biotech Ltd.

Via GlobeNewswire

What's going on in today's after hours session ↗

November 07, 2025

Via Chartmill

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 07, 2025

Via Benzinga

Get insights into the top gainers and losers of Thursday's pre-market session. ↗

October 30, 2025

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 30, 2025

Via Benzinga

Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

October 30, 2025

Via Benzinga

Curious about the most active stocks on Wednesday? ↗

October 29, 2025

Via Chartmill

Keep an eye on the top gainers and losers in Wednesday's session. ↗

October 29, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 29, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

October 29, 2025

Via Chartmill

Dow Surges 250 Points; Verizon Posts Mixed Q3 Results ↗

October 29, 2025

Via Benzinga

Purple Biotech Shares Soar 92% On Breakthrough For Experimental Cancer Drug ↗

October 29, 2025

Via Stocktwits

Get insights into the top gainers and losers of Wednesday's pre-market session. ↗

October 29, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 29, 2025

Via Benzinga

Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform

October 29, 2025

From Purple Biotech Ltd.

Via GlobeNewswire

Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification

October 20, 2025

From Purple Biotech Ltd.

Via GlobeNewswire

Purple Biotech Receives Intention to Grant a European Patent Covering NT219 Combinations with Immunotherapies or MEK Inhibitors to Overcome Tumor Resistance

September 10, 2025

From Purple Biotech Ltd.

Via GlobeNewswire

Frequently Asked Questions

Is Purple Biotech Ltd. - American Depositary Shares publicly traded?

Yes, Purple Biotech Ltd. - American Depositary Shares is publicly traded.

What exchange does Purple Biotech Ltd. - American Depositary Shares trade on?

Purple Biotech Ltd. - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Purple Biotech Ltd. - American Depositary Shares?

The ticker symbol for Purple Biotech Ltd. - American Depositary Shares is PPBT on the Nasdaq Stock Market

What is the current price of Purple Biotech Ltd. - American Depositary Shares?

The current price of Purple Biotech Ltd. - American Depositary Shares is 4.005

When was Purple Biotech Ltd. - American Depositary Shares last traded?

The last trade of Purple Biotech Ltd. - American Depositary Shares was at 03/27/26 01:54 PM ET

What is the market capitalization of Purple Biotech Ltd. - American Depositary Shares?

The market capitalization of Purple Biotech Ltd. - American Depositary Shares is 68.93M

How many shares of Purple Biotech Ltd. - American Depositary Shares are outstanding?

Purple Biotech Ltd. - American Depositary Shares has 69M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.